[On the preliminary results of the use of hyperbaric oxygenation in ocular pathology].
D003930:Diabetic Retinopathy / Q000628:therapy; D005128:Eye Diseases / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000009:adverse effects; D009896:Optic Atrophy / Q000628:therapy; D009902:Optic Neuritis / Q000628:therapy; D012161:Retinal Artery; D012162:Retinal Degeneration / Q000628:therapy; D012169:Retinal Vein; D012174:Retinitis Pigmentosa / Q000628:therapy; D013924:Thrombophlebitis / Q000628:therapy; D013927:Thrombosis / Q000628:therapy; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use; D014792:Visual Acuity; D014794:Visual Fields
D005343:Fibrinolytic Agents; D014665:Vasodilator Agents
A propos de nos premiers résultats sur l'ap-lication de l'oxygénation hyperbare en pathologie oculaire.